The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity
Open accessAbstract
Microneedle patches coated with solid-state influenza vaccine have been developed to improve vaccine efficacy and patient coverage. However, dip coating microneedles with influenza vaccine can reduce antigen activity. In this study, we sought to determine the experimental factors and mechanistic pathways by which inactivated influenza vaccine can lose activity, as well as develop and assess improved microneedle coating formulations that protect the antigen from activity loss. After coating microneedles using a standard vaccine formulation, antigenicity was reduced to just 2%, as measured by hemagglutination activity. The presence of carboxymethylcellulose, which was added to increase viscosity of the coating formulation, was shown to contribute to vaccine activity loss. After screening a panel of candidate stabilizers, the addition of trehalose to the coating formulation was shown to protect the antigen and retain 48–82% antigen activity for all three major strains of seasonal influenza: H1N1, H3N2 and B. Influenza vaccine coated in this way also exhibited thermal stability, such that activity loss was independent of temperature over the range of 4 – 37°C for 24 h. Dynamic light scattering measurements showed that antigen activity loss was associated with virus particle aggregation, and that stabilization using trehalose largely blocked this aggregation. Finally, microneedles using an optimized vaccine coating formulation were applied to the skin to vaccinate mice. Microneedle vaccination induced robust systemic and functional antibodies and provided complete protection against lethal challenge infection similar to conventional intramuscular injection. Overall, these results show that antigen activity loss during microneedle coating can be largely prevented through optimized formulation and that stabilized microneedle patches can be used for effective vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
Hobson, D., Curry, R. L., Beare, A. S., & Ward-Gardner, A. (1972) · Epidemiology and Infection · doi:10.1017/s0022172400022610 · Cited by 1,002
Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying
Leslie, S. B., Israeli, E., Lighthart, B., Crowe, J. H., & Crowe, L. M. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.10.3592-3597.1995 · Cited by 977
Stabilization of dry phospholipid bilayers and proteins by sugars
Crowe, J. H., Crowe, L. M., Carpenter, J. F., & Aurell Wistrom, C. (1987) · Biochemical Journal · doi:10.1042/bj2420001 · Cited by 924
Coated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Self-citationAn infrared spectroscopic study of the interactions of carbohydrates with dried proteins
Carpenter, J. F., & Crowe, J. H. (1989) · Biochemistry · doi:10.1021/bi00435a044 · Cited by 758
Effect of Microneedle Design on Pain in Human Volunteers
Gill, H. S., Denson, D. D., Burris, B. A., & Prausnitz, M. R. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816778f9 · Cited by 701
Self-citationNicholson, K. G., Wood, J. M., & Zambon, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14854-4 · Cited by 691
Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer, D. A. (1999) · Virology · doi:10.1006/viro.1999.9716 · Cited by 663
Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo
Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K., Selby, M. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4635 · Cited by 606
Influenza: old and new threats
Palese, P. (2004) · Nature Medicine · doi:10.1038/nm1141 · Cited by 603
Cox, R. J., Brokstad, K. A., & Ogra, P. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01382.x · Cited by 553
Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis
Vyas, G. N., & Shulman, N. R. (1970) · Science · doi:10.1126/science.170.3955.332 · Cited by 479
Dose Sparing with Intradermal Injection of Influenza Vaccine
Kenney, R. T., Frech, S. A., Muenz, L. R., Villar, C. P., & Glenn, G. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043540 · Cited by 422
Mikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., & Harvey, N. G. (2002) · Nature Medicine · doi:10.1038/nm0402-415 · Cited by 398
Matriano, J. A., Cormier, M., Johnson, J., Young, W. A., Buttery, M., Nyam, K., & Daddona, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1013607400040 · Cited by 373
Serum Antibody Responses after Intradermal Vaccination against Influenza
Belshe, R. B., Newman, F. K., Cannon, J., Duane, C., Treanor, J., Van Hoecke, C., Howe, B. J., & Dubin, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043555 · Cited by 332
Van Damme, P., Oosterhuis-Kafeja, F., Van der Wielen, M., Almagor, Y., Sharon, O., & Levin, Y. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.10.077 · Cited by 331
Stability of dry liposomes in sugar glasses
Sun, W. Q., Leopold, A. C., Crowe, L. M., & Crowe, J. H. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79740-0 · Cited by 329
Prausnitz, M. R., Mikszta, J. A., Cormier, M., & Andrianov, A. K. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-92165-3_18 · Cited by 314
Self-citationHolland, D., Booy, R., Looze, F. D., Eizenberg, P., McDonald, J., Karrasch, J., McKeirnan, M., Salem, H., Mills, G., Reid, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590434 · Cited by 254
Laurent, P. E., Bonnet, S., Alchas, P., Regolini, P., Mikszta, J. A., Pettis, R., & Harvey, N. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.020 · Cited by 213
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge
Zhu, Q., Zarnitsyn, V. G., Ye, L., Wen, Z., Gao, Y., Pan, L., Skountzou, I., Gill, H. S., Prausnitz, M. R., Yang, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812652106 · Cited by 211
Self-citationWIDERA, G., JOHNSON, J., KIM, L., LIBIRAN, L., NYAM, K., DADDONA, P., & CORMIER, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.049 · Cited by 208
Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays
Koutsonanos, D. G., Martin, M. D. P., Zarnitsyn, V. G., Sullivan, S. P., Compans, R. W., Prausnitz, M. R., & Skountzou, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004773 · Cited by 198
Self-citationTrehalose lowers membrane phase transitions in dry yeast cells
Leslie, S., Teter, S. A., Crowe, L. M., & Crowe, J. H. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90136-8 · Cited by 193
Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
Amorij, J.-P., Huckriede, A., Wilschut, J., Frijlink, H. W., & Hinrichs, W. L. J. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9559-6 · Cited by 186
Azzi, L., El-Alfy, M., Martel, C., & Labrie, F. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23545.x · Cited by 178
Allison, S. D., Molina, M. D. C., & Anchordoquy, T. J. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00251-0 · Cited by 177
Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization
Quan, F., Compans, R. W., Nguyen, H. H., & Kang, S. (2007) · Journal of Virology · doi:10.1128/jvi.01615-07 · Cited by 150
Self-citationRecommendations of the Advi sory Committee on Immunization Practices
anning, S. E. M., Rupprecht, C. E., Fishbein, D. B., Hanlon, C. A., Lumlertdacha, B., Meltzer, I., Jenkins, S. R., Sun, B., & Hull, H. F. (2008) · Cited by 141
In VivoGene Transfer to Skin and Wound by Microseeding
Eriksson, E., Yao, F., Svensjö, T., Winkler, T., Sláma, J., Macklin, M. D., Andree, C., McGregor, M. W., Hinshaw, V. S., & Swain, W. F. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5325 · Cited by 125
Carpenter, J. F., Martin, B., Crowe, L. M., & Crowe, J. H. (1987) · Cryobiology · doi:10.1016/0011-2240(87)90049-6 · Cited by 122
Leroux‐Roels, I., Vets, E., Freese, R., Seiberling, M., Weber, F., Salamand, C., & Leroux-Roels, G. G. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.078 · Cited by 121
Bramson, J. L., Dayball, K., Evelegh, C. M., Wan, Y., Page, D. T. P., & Smith, A. M. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301886 · Cited by 118
Amorij, J.-P., Meulenaar, J., Hinrichs, W. L. J., Stegmann, T., Huckriede, A. L. W., Coenen, F., & Frijlink, H. W. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.054 · Cited by 109
Transcutaneous immunization with inactivated influenza virus induces protective immune responses
Skountzou, I., Quan, F., Jacob, J., Compans, R. W., & Kang, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.014 · Cited by 88
Self-citationTranscutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch
Glenn, G. M., Flyer, D. C., Ellingsworth, L. R., et al. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.809 · Cited by 68
Stabilization of Active Recombinant Retroviruses in an Amorphous Dry State with Trehalose
Bieganski, R. M., Fowler, A., Morgan, J. R., & Toner, M. (1998) · Biotechnology Progress · doi:10.1021/bp980057d · Cited by 58
Epidermal Dendritic Cells Induce Potent Antigen-Specific CTL-Mediated Immunity
Celluzzi, C. M., & Falo, L. D. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12292095 · Cited by 53
Low-volume jet injection for intradermal immunization in rabbits
Ren, S. V., Li, M., Smith, J. M., DeTolla, L. J., & Furth, P. A. (2002) · BMC Biotechnology · doi:10.1186/1472-6750-2-10 · Cited by 44
Vaccines against epidemic and pandemic influenza
Hoelscher, M., Gangappa, S., Zhong, W., Jayashankar, L., & Sambhara, S. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1139 · Cited by 29
Bioneedles™ as vaccine carriers
Hirschberg, H. J. H. B., van de Wijdeven, G. G. P., Kelder, A. B., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.067 · Cited by 25
Bevel-Down Superior to Bevel-Up in Intradermal Skin Testing
Howard, A., Mercer, P., Nataraj, H. G., & Kang, B. C. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63222-x · Cited by 25
Analysis of delay times of hemagglutinin-mediated fusion between influenza virus and cell membranes
Ludwig, K., Korte, T., & Herrmann, A. (1995) · European Biophysics Journal · doi:10.1007/bf00211399 · Cited by 10
Cited by
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Self-citationMicroneedle technologies for (trans)dermal drug and vaccine delivery
van der Maaden, K., Jiskoot, W., & Bouwstra, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.042 · Cited by 651
Microneedles for intradermal and transdermal drug delivery
Tuan-Mahmood, T.-M., McCrudden, M. T. C., Torrisi, B. M., McAlister, E., Garland, M. J., Singh, T. R. R., & Donnelly, R. F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.005 · Cited by 468
Microneedles: an emerging transdermal drug delivery system
Bariya, S. H., Gohel, M. C., Mehta, T. A., & Sharma, O. P. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01369.x · Cited by 455
Skin permeabilization for transdermal drug delivery: recent advances and future prospects
Schoellhammer, C. M., Blankschtein, D., & Langer, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.875528 · Cited by 376
Metadata
- Authors
- Kim, Y.-C., Quan, F.-S., Compans, R. W., Kang, S.-M., & Prausnitz, M. R.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 142
- Issue
- 2
- Pages
- 187-195
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2054469972
- Cited by
- 255
- References
- 47
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.